{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:54:45Z","timestamp":1792508085320,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To offer an estimate of the incidence of anaphylactic reactions to parenteral products containing thiamine used in the treatment of Wernicke\u2019s encephalopathy (WE) and make recommendations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>Review of previously released data on some older products and parenteral thiamine use in some other countries; analysis of sales and adverse incident data on anaphylaxis for a contemporary parenteral product used in the UK, Pabrinex.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>It was difficult to estimate the incidence of related anaphylactic reactions to Pabrinex in the UK because the number of doses given is unknown. Sales data are only an approximation to doses given because for products with a limited shelf life not all product sold is administered. However, available data indicate that there have been 10 anaphylactic reactions to Pabrinex from between 5,431,235\u20136,651,947 patient-days (14,880\u201316,080 years) of treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>It is reasonable to assume that the risk of anaphylaxis is low, and lower than for many other drugs. The risk-benefit ratio for administration is favourable given the potential severity of brain damage in Wernicke\u2013Korsakoff (WK) syndrome. There is a need for international agreement on the reporting of anaphylaxis and on the optimum thiamine therapy for the treatment of WK syndrome. We make recommendations on how this might be achieved.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/alcalc\/agy091","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T20:48:32Z","timestamp":1548362912000},"page":"609-614","source":"Crossref","is-referenced-by-count":17,"title":["Incidence of Adverse Reactions to Parenteral Thiamine in the Treatment of Wernicke\u2019s Encephalopathy, and Recommendations"],"prefix":"10.1093","volume":"54","author":[{"given":"Allan","family":"Thomson","sequence":"first","affiliation":[{"name":"King\u2019s College London, Institute of Psychiatry, Psychology and Neuroscience London SE5 8AF, UK"},{"name":"Division of Psychiatry, University College London, Rockefeller Building, Gower Street, London WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Guerrini","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Institute of Psychiatry, Psychology and Neuroscience London SE5 8AF, UK"},{"name":"Bexley Substance Misuse Service, South London and Maudsley NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Jane","family":"Marshall","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Institute of Psychiatry, Psychology and Neuroscience London SE5 8AF, UK"},{"name":"Addictions Clinical Academic Group, South London and Maudsley NHS Foundation Trust, Marina House, 63-65 Denmark Hill, London SE58RS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"2019120601131332800_agy091C1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/alcalc\/agh106","article-title":"Thiamine administration in alcohol-dependent patients","volume":"40","author":"Agabio","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C2","first-page":"179","article-title":"Thiamine prescribing for adult patients admitted to an internal medicine service","volume":"70","author":"Alim","year":"2017","journal-title":"Can J Hosp Pharm"},{"key":"2019120601131332800_agy091C3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/all.12677","article-title":"Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement","volume":"70","author":"Ansley","year":"2015","journal-title":"Allergy"},{"key":"2019120601131332800_agy091C4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/alcalc\/agt043","article-title":"Response to \u2018BNF recommendations for the treatment of Wernicke\u2019s encephalopathy: lost in translation?\u2019","volume":"48","author":"BNF Editorial Team BNF","year":"2013","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaci.2014.08.024","article-title":"Using a gluten oral food challenge protocol to improve diagnosis of wheat-dependent exercise-induced anaphylaxis","volume":"135","author":"Brockow","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2019120601131332800_agy091C6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/jnnp.62.1.51","article-title":"Operational criteria for the classification of chronic alcoholics: identification of Wernicke\u2019s encephalopathy","volume":"62","author":"Caine","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019120601131332800_agy091C7","first-page":"1677","volume-title":"Neurological Therapeutics","author":"Charness","year":"2006"},{"key":"2019120601131332800_agy091C8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/oxfordjournals.alcalc.a008400","article-title":"B-vitamin deficiency and neuro-psychiatric syndromes in alcohol misuse","volume":"33","author":"Cook","year":"1998","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C9","first-page":"CD004033","article-title":"Thiamine for prevention and treatment of Wernicke- Korsakoff Syndrome in people who abuse alcohol","volume":"7","author":"Day","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2019120601131332800_agy091C10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jhm.2324","article-title":"Thiamine prescribing practices within university-affiliated hospitals: a multicenter retrospective review","volume":"10","author":"Day","year":"2015","journal-title":"J Hosp Med"},{"key":"2019120601131332800_agy091C11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International Consensus on drug allergy","volume":"69","author":"Demoly","year":"2015","journal-title":"Allergy"},{"key":"2019120601131332800_agy091C12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1468-1331.2010.03153.x","article-title":"EFNS guidelines for diagnosis, therapy and prevention of Wernicke\u2019s encephalopathy","volume":"17","author":"Galvin","year":"2010","journal-title":"Eur J Neurol"},{"key":"2019120601131332800_agy091C13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jnnp.46.7.593","article-title":"The incidence of Wernicke\u2019s encephalopathy in Australia: a neuropathological study of 131 cases","volume":"46","author":"Harper","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019120601131332800_agy091C14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01991779","article-title":"An international perspective on the prevalence of the Wernicke-Korsakoff syndrome","volume":"10","author":"Harper","year":"1995","journal-title":"Metab Brain Dis"},{"key":"2019120601131332800_agy091C15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jnnp.49.4.341","article-title":"Clinical signs in Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at autopsy","volume":"49","author":"Harper","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019120601131332800_agy091C16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.5694\/j.1326-5377.1998.tb139081.x","article-title":"Prevalence of Wernicke-Korsakoff Syndrome in Australia: has thiamine fortification made a difference?","volume":"168","author":"Harper","year":"1998","journal-title":"Med J Aust"},{"key":"2019120601131332800_agy091C17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaci.2014.11.003","article-title":"Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production","volume":"135","author":"Hox","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2019120601131332800_agy091C18","author":"Kyowa Kirin Ltd","year":"2016"},{"key":"2019120601131332800_agy091C19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/imj.12522","article-title":"Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use","volume":"44","author":"Latt","year":"2014","journal-title":"Intern Med J"},{"key":"2019120601131332800_agy091C20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","article-title":"Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group","volume":"97","author":"Lieberman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2019120601131332800_agy091C21","first-page":"8","article-title":"Drug safety advice. Pabrinex: allergic reactions","volume":"1","author":"MHRA","year":"2007","journal-title":"MHRA Drug Saf Update"},{"key":"2019120601131332800_agy091C22","author":"NICE","year":"2010"},{"key":"2019120601131332800_agy091C23","author":"NICE","year":"2011"},{"key":"2019120601131332800_agy091C24","author":"NICE","year":"2011"},{"key":"2019120601131332800_agy091C25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/alcalc\/agt179","article-title":"BNF recommendations for the treatment of Wernicke\u2019s encephalopathy: lost in translation?","volume":"49","author":"Oudman","year":"2014","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1192\/pb.19.12.788","article-title":"Parenteral vitamin therapy in alcoholism","volume":"19","author":"O\u2019Brien","year":"1995","journal-title":"Psychiatr Bull"},{"key":"2019120601131332800_agy091C28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions","volume":"30","author":"Pumphrey","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"2019120601131332800_agy091C29","author":"Resuscitation Council (UK)","year":"2008"},{"key":"2019120601131332800_agy091C30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"key":"2019120601131332800_agy091C31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/alcalc\/agt124","article-title":"Wernicke\u2013Korsakoff\u2019s syndrome: waiting for godot?","volume":"49","author":"Soler-Gonz\u00e1lez","year":"2014","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/qjmed\/89.11.859","article-title":"The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department","volume":"89","author":"Stewart","year":"1996","journal-title":"Q J Med"},{"key":"2019120601131332800_agy091C33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/alcalc\/agm149","article-title":"Wernicke\u2019s encephalopathy: \u2018plus ca change, plus c\u2019est la meme chose\u2019","volume":"43","author":"Thomson","year":"2008","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/alcalc\/37.6.513","article-title":"The Royal College of Physicians report on alcohol: guidelines for managing Wernicke\u2019s encephalopathy in the accident and emergency department","volume":"37","author":"Thomson","year":"2002","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11065-012-9196-z","article-title":"The evolution and treatment of Korsakoff\u2019s syndrome. Out of sight, out of mind? (2012)","volume":"22","author":"Thomson","year":"2012","journal-title":"Neuropsychol Rev"},{"key":"2019120601131332800_agy091C36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/alcalc\/agt034","article-title":"BNF recommendations for the treatment of Wernicke\u2019s encephalopathy: lost in translation?","volume":"48","author":"Thomson","year":"2013","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/alcalc\/ags111","article-title":"Time to act on the inadequate management of Wernicke\u2019s encephalopathy in the UK","volume":"48","author":"Thomson","year":"2013","journal-title":"Alcohol Alcohol"},{"key":"2019120601131332800_agy091C38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992\u20132012","volume":"135","author":"Turner","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2019120601131332800_agy091C39","volume-title":"The Wernicke\u2013Korsakoff Syndrome and Related Neurological Disorders due to Alcoholism","author":"Victor","year":"1989"},{"key":"2019120601131332800_agy091C40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40258-015-0214-1","article-title":"The long-term cost to the UK NHS and social services of different durations of IV thiamine (vitamin B1) for chronic alcohol misusers with symptoms of Wernicke\u2019s encephalopathy presenting at the emergency department","volume":"14","author":"Wilson","year":"2016","journal-title":"Appl Health Econ Health Policy"},{"key":"2019120601131332800_agy091C41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0196-0644(89)80215-X","article-title":"A toxicity study of parenteral thiamine hydrochloride","volume":"18","author":"Wrenn","year":"1989","journal-title":"Ann Emerg Med"},{"key":"2019120601131332800_agy091C42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0735-6757(92)90054-2","article-title":"Is intravenous thiamine safe?","volume":"10","author":"Wrenn","year":"1992","journal-title":"Am J Emerg Med"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/alcalc\/article-pdf\/54\/6\/609\/31234205\/agy091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/alcalc\/article-pdf\/54\/6\/609\/31234205\/agy091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T01:13:28Z","timestamp":1575594808000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/alcalc\/article\/54\/6\/609\/5576058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,9,30]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agy091","relation":{},"ISSN":["0735-0414","1464-3502"],"issn-type":[{"value":"0735-0414","type":"print"},{"value":"1464-3502","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,9,30]]}}}